OMV AG/ AT0000743059 /
2024-08-02 10:30:37 AM | Chg. +0.200 | Volume | Bid10:37:17 AM | Ask10:37:17 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
38.600EUR | +0.52% | 350 Turnover: 13,369 |
38.860Bid Size: 250 | 38.880Ask Size: 250 | 12.63 bill.EUR | 13.08% | 8.53 |
GlobeNewswire
03-26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
01-16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
2023-09-14
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
2021-10-13
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center